BY MARKETWIRE
-
Interacoustics launches new audiometer with touch function
It worries a traditional PC-based audiometer for hearing examinations in both health centers and audiologists’ workplaces. As a brand-new attribute, the item has a touch key-…
-
Lundbeck expands migraine candidate study with intravenous dosing
Lundbeck is increasing its Proceed research with migraine prospect Lu AG09222 to consist of intravenous application, which is shot straight right into a blood vessel.
-
Novo Nordisk acquires obesity drug candidate from Lexicon Pharmaceutical
Vocabulary will certainly complete an application to authorities to begin human research studies with the medicine prospect provisionally called LX9851.
-
Danish Shareholders’ Association proposes full-time chairmanship at Novo Nordisk
Novo Nordisk’s Chairman of the Board, Helge Lund, mentions that the Board is well staffed with participants that have considerable and extensive understanding of the market.
-
Zealand Pharma sharpens focus on future pipeline following petrelintid deal
Chairman is “deeply honored and amazed” that Zealand Pharma has actually protected the handle Roche.
-
Morgan Stanley eyes outlook downgrade from Novo Nordisk
In the United States, prescriptions for the hit medication Wegovy have actually gone stale.
-
Novo Nordisk slides six trading days in a row: Heading for two-year low
Since Novo Nordisk set a closing report of DKK 1,028 on June 25 final yr, the share has greater than halved in worth.
-
Johnson & Johnson reveals five-year investment budget raise to USD 55bn
Cash will certainly be invested in 4 brand-new manufacturing facilities, to name a few points.
-
Pfizer offloads Haleon shares worth GBP 2.5bn
Haleon creates numerous over the counter health and wellness items and medications.
-
Media: US compounders won’t stop making patented weight-loss drugs
Hims & Hers Health and wellness will certainly remain to supply pharmaceutical variations of Ozempic and Wegovy, reports The Wall surface Road Journal, and various other firms…
